An electronic newsletter and interim supplement on Japanese encephalitis

Published 2004–2009, JE Newsbriefs was a quarterly electronic newsletter for global health experts. It provided updates on PATH’s work to increase the availability in the developing world of a vaccine against Japanese encephalitis—a mosquito-borne illness that can cause severe neurological disability or death.

Click on the links below to access past issues of JE Newsbriefs archived in PATH’s Vaccine Resource Library.

November 2009—final issue

  • Cambodia introduces JE vaccine through routine immunization
  • Biregional meeting on JE control looks at progress and next steps
  • PATH’s JE project closes, JE control continues

May 2009

  • Coalition of partners to maintain momentum of JE control
  • CDIBP proceeds with commissioning of new JE vaccine production facility
  • Intercell’s IC51 JE vaccine for travelers gains regulatory approvals

January 2009

  • JE Control by 2015 details sustainable priorities for the future
  • CDIBP JE vaccine facility nears mechanical completion
  • GAVI Alliance commits to seek funding for JE vaccine introduction support

August 2008

  • International symposium presents advances in JE detection and prevention
  • Vaccine production facilities unharmed in Chengdu’s major earthquake
  • The Lancet article highlights inclusion of JE in GAVI Alliance strategy

April 2008

  • India aims to vaccinate 20 million more in third year of JE immunization strategy
  • WHO advisory committee acknowledges safety of coadministering live JE and measles vaccines
  • Cohort study assesses WHO JE surveillance standards

November 2007

  • Follow-up study shows long-term protection when measles and JE vaccines are given together
  • Groundbreaking ceremony held for new facility at Chengdu Institute
  • Studies initiated to advance JE control in Sri Lanka

June 2007

  • Biregional meeting marks progress and maps out next steps
  • Study demonstrates long-term protection from single dose of SA 14-14-2 JE vaccine
  • India and Nepal expand JE vaccination campaigns

January 2007

  • JE immunization highlighted at Global Vaccine Research Forum
  • WHO/SEARO issues guidelines on SA 14-14-2 vaccine introduction
  • Partner profile: Center for Vaccine Development, Mahidol University

September 2006

  • India protects 9 million children against JE
  • Nepal safeguards 2 million children
  • WHO updates position paper on JE vaccines
  • Partner profile: Technip
  • SEARO laboratory network established

May 2006

  • India approves licensure of SA 14-14-2 vaccine
  • Public-sector pricing established
  • Strategic Advisory Group of Experts addresses JE control through immunization
  • JE Project-supported studies

December 2005

  • JE outbreak in India
  • WHO committee reviews safety and efficacy of SA 14-14-2 vaccine
  • JE control highlighted in BBC World documentary

March 2005

  • New JE e-learning tool on web and CD-ROM
  • Nepal prepares the way for better JE control
  • Partner profile: AFRIMS in Thailand

October 2004

  • JE on the move
  • Interactive JE reporting system to debut in India
  • Indonesia plans first nationwide assessment of JE
  • The JE Core Working Group